Cambridge Investment Research Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $544K | Buy |
|
|||||
|
2025
Q4 | $506K | Sell |
|
|||||
|
2025
Q3 | $514K | Buy |
|
|||||
|
2025
Q2 | $394K | Buy |
|
|||||
|
2025
Q1 | $247K | Hold |
|
|||||
|
2024
Q4 | $363K | Hold |
|
|||||
|
2024
Q3 | $427K | Sell |
|
|||||
|
2024
Q2 | $299K | Hold |
|
|||||
|
2024
Q1 | $403K | Buy |
|
|||||
|
2023
Q4 | $229K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $207K | Hold |
|
|||||
|
2023
Q1 | $267K | Hold |
|
|||||
|
2022
Q4 | $225K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $381K | Hold |
|
|||||
|
2021
Q4 | $572K | Hold |
|
|||||
|
2021
Q3 | $529K | Sell |
|
|||||
|
2021
Q2 | $442K | Buy |
|
|||||
|
2021
Q1 | $350K | Hold |
|
|||||
|
2020
Q4 | $559K | Buy |
|